Cargando…
The Caspase 1 Inhibitor VX-765 Protects the Isolated Rat Heart via the RISK Pathway
PURPOSE: Protecting the heart from ischaemia-reperfusion (IR) injury is a major goal in patients presenting with an acute myocardial infarction. Pyroptosis is a novel form of cell death in which caspase 1 is activated and cleaves interleukin 1β. VX-785 is a highly selective, prodrug caspase 1 inhibi...
Autores principales: | Do Carmo, Helison, Arjun, Sapna, Petrucci, Orlando, Yellon, Derek M, Davidson, Sean M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5958154/ https://www.ncbi.nlm.nih.gov/pubmed/29582211 http://dx.doi.org/10.1007/s10557-018-6781-2 |
Ejemplares similares
-
VX‐765 ameliorates renal injury and fibrosis in diabetes by regulating caspase‐1‐mediated pyroptosis and inflammation
por: Wen, Si, et al.
Publicado: (2021) -
VX765, a Specific Caspase-1 Inhibitor, Alleviates Lung Ischemia Reperfusion Injury by Suppressing Endothelial Pyroptosis and Barrier Dysfunction
por: Wu, Siyi, et al.
Publicado: (2021) -
Novel role for caspase 1 inhibitor VX765 in suppressing NLRP3 inflammasome assembly and atherosclerosis via promoting mitophagy and efferocytosis
por: Jin, Ying, et al.
Publicado: (2022) -
VX-765 has a Protective Effect on Mice with Ovarian Injury Caused by Chemotherapy
por: Lee, Pingyin, et al.
Publicado: (2023) -
VX-765 reduces neuroinflammation after spinal cord injury in mice
por: Chen, Jing, et al.
Publicado: (2021)